×
For best experience we recommend to activate Javascript in your browser.
AGXT antibody (AA 63-247)
The Rabbit Polyclonal anti-AGXT antibody has been validated for WB, IHC, IP and ICC. It is suitable to detect AGXT in samples from Human.
Quick Overview for AGXT antibody (AA 63-247) (ABIN7610768)
Target
See all AGXT Antibodies
AGXT
(Alanine Glyoxylate Aminotransferase (AGXT))
Reactivity
All reactivities for AGXT antibodies
Human
Host
All hosts for AGXT antibodies
Rabbit
Clonality
All clonalities for AGXT antibodies
Polyclonal
Conjugate
All conjugates for AGXT antibodies
This AGXT antibody is un-conjugated
Application
All applications for AGXT antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-AGXT Antibody
(hide)
Binding Specificity
All epitopes for AGXT antibodies
AA 63-247
Purpose
Alanine Glyoxylate Aminotransferase (AGXT) Polyclonal Antibody
Sequence
Gly63~Leu247
Characteristics
The Alanine Glyoxylate Aminotransferase (AGXT) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.88 mg/mL
Buffer
PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for AGXT
(hide)
Target
AGXT
(Alanine Glyoxylate Aminotransferase (AGXT))
Alternative Name
AGXT
Gene ID
189
UniProt
P21549
Pathways
Monocarboxylic Acid Catabolic Process , Dicarboxylic Acid Transport
Recently viewed
(hide)
Chat with us , powered by LiveChat